horses
trial name
conditions
enrollment ends
Immunotherapy for the treatment of corneolimbal squamous cell carcinoma in the horse
corneolimbal squamous cell carcinoma
July 1, 2025
Immunotherapy for the treatment of genital squamous cell carcinoma in the horse
squamous cell carcinoma
June 1, 2026
Immunotherapy for treatment of periocular sarcoids in the horse
periocular sarcoids
July 1, 2025
Prostride clinical trial
lameness
June 1, 2026